Earnings Calls News and Headlines
Earnings Calls News and Headlines
Orthofix Medical reported fourth‑quarter 2020 net sales of $118 million, a 3% decline year‑over‑year but a 6% sequential increase. Spine implant revenue grew 9% YoY, propelled by an 11% rise in U.S. M6 disc sales, while motion‑preservation revenue jumped 129% YoY. Biologics and extremities businesses faced double‑digit declines due to COVID‑related elective procedure slowdowns. The company highlighted a strengthened cash position of $97 million, new product launches, and a $10 million partnership with Neo Medical to expand single‑use spinal instruments.
Herc Holdings reported a transformative fourth‑quarter 2025, with equipment rental revenue climbing 24% year‑over‑year after the June H&E acquisition and strong mega‑project demand. Adjusted EBITDA rose 19% to $2.0‑2.1 billion for 2026 guidance, while used equipment sales surged 53% but pressured...
First Solar reported record 2025 module shipments of 17.5 GW, a 24% increase year‑over‑year, and net sales of $5.2 billion at the top of its guidance range. Gross margin fell to 41% from 44% due to tariff costs and under‑utilized overseas plants,...
Global Industrial reported Q2 2025 revenue of $358.9 million, up 3.2% year‑over‑year, and posted a record gross margin of 37.1%, a 190‑basis‑point improvement. Operating income reached $33.5 million, lifting operating margin to 9.3% as strategic accounts drove growth while smaller...
Day One Biopharmaceuticals reported a breakout 2025, with Ojemda generating $155.4 million in net product revenue—a 172% year‑over‑year increase—and over 4,600 prescriptions. The company achieved its first profitability milestone as Ojemda’s revenue exceeded combined cost of sales and SG&A, while ending...
CareDx reported Q4 2025 revenue of $108.4 million, up 25% year‑over‑year, propelled by testing services and a 47% surge in patient‑digital solutions. Adjusted EBITDA fell 34% because of a $6.7 million one‑time executive bonus, while cash balances reached $201 million and the company...
Medifast reported Q4 2025 revenue of $75.1 million, down 36.9% year‑over‑year, as the active earning coach base shrank 40.6% to roughly 16,100. Despite the top‑line decline, average revenue per coach increased 6.2% to $4,664, marking the first year‑over‑year productivity gain since...
NRG Energy reported a 32% year‑over‑year rise in adjusted EPS to $2.78 and a record $1.205 billion adjusted EBITDA for Q3 2025, driven by strong performance in its Texas and smart‑home segments. Free cash flow before growth hit $828 million for the...
New Mountain Finance Corp reported Q2 2025 adjusted net investment income of $0.32 per share, fully covering its quarterly dividend and underscoring the effectiveness of its dividend protection program through 2026. Net asset value slipped to $12.21 per share, a...
BridgeBio Pharma reported Q4 2025 revenue of $120.7 million, a surge driven primarily by Attruby net product sales of $108.1 million and expanding royalty streams. The company announced statistically significant Phase III readouts for BBP-418 in limb‑girdle muscular dystrophy and...
Harmony Biosciences reported $714.7 million net product revenue for 2024, a 23% year‑over‑year increase, with Q4 sales of $201.3 million driven largely by its flagship narcolepsy drug Wakix. The company announced a generic settlement with Novogen that postpones competition until at least...
Leonardo DRS reported Q2 FY2025 revenue of $829 million, up 10% year‑over‑year, and adjusted EBITDA of $96 million, expanding margin to 11.6%. Bookings reached $853 million with a 1.0 book‑to‑bill ratio and total backlog grew 9% to $8.6 billion. The company raised its full‑year...
Sotera Health reported Q2 2025 revenue of $294 million, up 6.4% year‑over‑year, and adjusted EBITDA of $151 million, lifting the margin to 51.2%. Growth was led by Sterigenics’ 10.5% revenue increase and Nelson Labs’ 514‑basis‑point margin expansion, while Nordion delivered modest gains despite...
Chimera Investment Corporation reported Q4 2025 GAAP net income of $7 million ($0.08 per share) and a full‑year profit of $144 million. The board increased the quarterly dividend 22% to $0.45 and signaled it will remain at that level through 2026. Integration...
Matson Inc. posted a mixed Q2 2025, with net income down 16.3% to $94.7 million and consolidated operating income falling $11.6 million to $113 million, driven primarily by a 14.6% drop in China container volumes. Hawaii and Alaska lanes showed modest growth, while...
Marqeta reported Q4 2024 total processed volume (TPV) of $80 billion, a 29% year‑over‑year increase, and net revenue of $136 million, up 14%. Adjusted EBITDA turned positive at $13 million, delivering a 9% margin, marking the company’s first profitable quarter. The firm announced...
Universal Insurance Holdings reported a strong Q4 2025, posting adjusted EPS of $1.36 and a 30.6% adjusted ROE. Core revenue rose 4.9% to $400 million, driven by higher net premiums earned and investment income, while the net loss ratio improved to...
SLR Investment Corp reported flat net investment income of $0.40 per share and a net income of $0.43 per share, delivering a 9.4% annualized return on equity for the quarter ended September 30, 2025. The firm’s NAV rose modestly to $18.21 per...
Incyte reported a strong Q4 2025, delivering $1.51 billion in revenue, a 28% year‑over‑year increase, and $5.14 billion for the full year, up 21%. Core products drove the surge: Jakafi posted $828 million in Q4 sales, Opsilura $207 million, and hematology/oncology sales jumped 121%...
NexPoint Residential Trust reported a narrowed Q3 2025 net loss of $7.8 million, or $0.31 per diluted share, while total revenue slipped to $62.8 million. Same‑store NOI rose 3.5% to $38.8 million, driven by a 6.3% drop in operating expenses and a $72...
Navitas Semiconductor reported Q3 2025 results that met guidance, but highlighted a decisive strategic shift called Navitas 2.0. The company is deprioritizing its low‑margin mobile business, especially in China, and reallocating resources toward high‑power markets such as AI data centers,...
Flywire reported Q4 2024 revenue of $112.8 million, a 17.4% year‑over‑year increase, and adjusted EBITDA that rose roughly 700 basis points, meeting the midpoint of its guidance. The company highlighted strong growth in its travel vertical—over 50% organic expansion making it...
AbCellera Biologics reported a transformative 2024, shifting from a partnership platform to a clinical‑stage biotech. The company advanced two internal antibody programs, ABCL635 and ABCL575, toward CTA filings in Q2 2025 and highlighted a $800 million liquidity position. It outlined a...
Elanco Animal Health reported fourth‑quarter 2024 revenue of $1.02 billion, a 1% decline on a reported basis but a 4% organic constant‑currency increase. The company highlighted six newly launched products, including Zenrelia and Credelio Quattro, driving $461 million of innovation revenue that exceeded...
FrontView REIT reported sequential revenue growth to $17.6 million and a 6.7% rise in adjusted funds from operations (AFFO) per share, reaching 32 cents. The REIT resolved nine of twelve previously troubled assets, achieving over 89% recovery on purchase price and re‑leasing...
Masco Corp reported fourth‑quarter 2025 results with net sales down 2% and operating profit of $259 million, yielding a 14.4% margin. The plumbing segment posted a 3% sales increase and a 16.3% margin, while the Decorative Architectural segment fell 15% with...
DigitalOcean reported Q4 2024 revenue of $205 million, a 13% year‑over‑year increase, and lifted net dollar retention to 99%, with core cloud services hitting 100% retention for the first time since mid‑2023. Higher‑spend "Scalers+" customers grew 17% in count, contributed 22%...
TelevisaUnivision reported a 5% YoY revenue decline to $4.8 billion in 2025, but highlighted the Direct‑to‑Consumer (DTC) segment as a bright spot. The Spanish‑language streamer Vix achieved full‑year profitability, contributing roughly a quarter of total revenue and 20% of adjusted OIBDA,...
Talos Energy reported adjusted EBITDA of $294 million and adjusted free cash flow of $99 million for the quarter, driven by cost‑saving initiatives and strong operational performance. Average production reached 93,300 barrels of oil equivalent per day, with oil comprising 69% of...
National MI Holdings reported a record 2025 year, posting $388.9 million net income (up 8%), diluted EPS of $4.92 (up 11%), and a 16.2% return on equity. Insurance in force reached $221.4 billion, while fourth‑quarter new insurance written hit $14.2 billion, driving total...
International General Insurance Holdings (IGIC) posted Q3 2025 net income of $33.5 million and $94.9 million for the first nine months, delivering a 20% annualized return on equity. The company saw gross premiums written dip 5% in Q3, driven by long‑tail pressure,...
Iovance Biotherapeutics reported third‑quarter product revenue of about $68 million, a 13% sequential increase, driven primarily by $58 million in Amtagvi sales and $10 million in Proleukin revenue. Gross margin improved to roughly 43% after a restructuring that cut cost of sales by...
Solaris Energy Infrastructure announced a major upsizing of its core power‑solutions contract to 900 MW with a seven‑year tenor, extending earnings visibility to 2033. The joint‑venture, in which Solaris holds a 50.1% stake, is fully financed by a $550 million senior secured...
Westlake Chemical Partners reported Q3 2025 net income of $15 million ($0.42 per unit) and consolidated net sales of $3.09 billion, reflecting the completion of the Petro 1 ethylene unit turnaround. Distributable cash flow matched earnings at $15 million but fell $3 million short of...
Huron Consulting Group reported record third‑quarter 2025 revenues, with RBR reaching $432.4 million, a 16.8% year‑over‑year increase. The Healthcare segment drove growth, posting a 19.9% rise in RBR and expanding operating‑income margin to 30.9%. Adjusted earnings per share climbed 25% to...
CTS Corporation reported fourth‑quarter 2025 revenue of $137 million, a 9% year‑over‑year increase, with diversified end markets now contributing 59% of total sales. The medical segment surged, posting a 41% quarterly sales jump and a 37% rise in bookings, while the...
Fulcrum Therapeutics reported a strong fourth‑quarter, posting $1.51 billion in revenue, a 28% year‑over‑year increase, and a full‑year 2025 revenue of $5.14 billion, up 21%. Core product sales accelerated, led by Jakafi’s $828 million Q4 revenue and Opsilura’s 28% sales jump to $207 million....
Lucid Group reported a record 2024 with 9,029 vehicles produced and 10,241 deliveries, a 71% year‑over‑year increase. GAAP gross margin narrowed to –114% from –225% a year earlier, signaling improving cost structure. The new Lucid Gravity SUV generated strong order...
American Well Corp (AHCO) reported Q4 2025 revenue of $55.3 million, a 22.1% YoY decline, as the company completed its pivot from a multi‑product telehealth provider to a pure SaaS platform. Subscription revenue now represents 53% of total revenue, reflecting...
Vanda Pharmaceuticals reported a 9% rise in total revenue to $216.1 million for 2025, driven primarily by a 24% jump in Fanapt sales and a successful bipolar disorder launch. The company secured FDA approval for tradipitant (Nirius) for motion‑sickness prevention, marking...
Xometry Inc. reported fourth‑quarter 2025 revenue of $2 billion, a 5% year‑over‑year increase, driven by modest LTL growth and higher yields. Adjusted EBITDA rose 11% to $312 million, with the LTL segment contributing $285 million, while adjusted diluted EPS climbed 18% to $0.88....
Par Pacific Holdings reported Q3 2025 adjusted EBITDA of $372 million, largely driven by a $200 million boost from small refinery exemptions. Throughput reached a near‑record 198,000 barrels per day and system‑wide production costs fell to a record low $6.13 per barrel....
Life Time Group Holdings reported Q2 2025 revenue of $761 million, up 14% year‑over‑year, driven by higher membership dues, enrollment fees, and incentive revenue. Net income rose 36.5% to $72.1 million, while adjusted EBITDA reached $211 million with a 27.7% margin, reflecting strong...
CTS Corporation reported fourth‑quarter 2025 revenue of $137 million, a 9% year‑over‑year increase, while sequentially falling 4%. Diversified end markets now represent 59% of total revenue, growing 16% YoY, driven by strong medical (+41% Q4) and industrial (+16% Q4) performance. Adjusted...
Evolent Health reported $2.55 billion in 2024 revenue, a 30% year‑over‑year increase, with adjusted EBITDA of $160.5 million landing at the low end of its guidance due to elevated oncology costs. The company announced two major contracts—a New England health plan covering...
TPG reported record Q4 2025 results, posting GAAP net income of $77 million and after‑tax distributable earnings of $304 million, or $0.71 per share. The firm raised a record $51 billion in capital in 2025, a 71% increase, and deployed a record $19 billion...
CAVA Group reported a 20% year‑over‑year revenue increase to $289.8 million in Q4 2025, driven by strong same‑restaurant sales growth of 1.9% and the opening of 17 net new locations, bringing the total to 415 restaurants. Restaurant‑level profit margin expanded to...
Restaurant Brands International reported 2.4% comparable sales growth and 5.3% system‑wide sales increase for 2025, delivering 8.3% organic adjusted operating income growth and a 10.7% rise in adjusted EPS to $3.69. Net restaurant growth slowed to 2.9%, the lowest point...
EOG Resources reported a record $4.7 billion free cash flow for 2025, returning 100% of that amount to shareholders through an 8% dividend increase and $2.5 billion of share repurchases. The company cut well costs by 7% by extending lateral lengths and...
Ceribell reported a 34% year‑over‑year revenue increase to $24.8 million in Q4 2025, reaching $89.1 million for the full year. Gross margins remained high at 87% for the quarter, with a cash balance of $159.3 million, while net loss widened to $13.5 million due...
